Eigler F W, Dostal G, Montag H, Jakubowski H D
Thorac Cardiovasc Surg. 1983 Feb;31(1):45-8. doi: 10.1055/s-2007-1020292.
During a 10-year period 242 patients underwent 259 renal artery reconstruction for correction of renovascular hypertension or preservation of renal function. Bilateral stenosis was found in 26 patients (10.7%). Twenty-five of the 259 renal arteries were totally occluded. Stenosis was atheroslcerotic in 147 patients, fibrodysplastic in 88 and of other origin in 7 patients. The operative procedures included thrombendarterectomy with or without patch plasty in 105 patients, resection and end-to-end-anastomosis in 68, reimplantation in 34, vein graft interposition in 32, and patch graft angioplasty in 14 patients.--Overall hospital mortality was 4.1%. Whereas there were no deaths in fibrodysplastic disease, it was 6.8% in atherosclerosis. The late mortality of 185 patients followed was 9.2%, stroke and myocardial infarction being the most common causes of death. Postoperatively, blood pressure was normal in 36% of patients with atherosclerosis and in 70% of those with fibrodysplastic disease. Blood pressure improved in 53% of the patients with fibrodysplastic disease. These relationships did not change significantly 2, 4, and 6 years after reconstruction. The results indicate the favorable prognosis of renal artery reconstruction in fibrodysplastic stenosis and the limitations of surgery in atherosclerosis in a non-selected group of patients. Although the introduction of percutaneous intraluminal dilatation widens the therapeutic possibilities for renovascular hypertension, exact indications and intensive after-care are still mandatory.
在10年期间,242例患者接受了259次肾动脉重建术,以纠正肾血管性高血压或保留肾功能。26例患者(10.7%)发现双侧狭窄。259条肾动脉中有25条完全闭塞。147例患者的狭窄为动脉粥样硬化性,88例为纤维发育不良性,7例为其他原因。手术方式包括105例患者行血栓内膜切除术加或不加补片成形术,68例行切除术和端端吻合术,34例行再植术,32例行静脉移植介入术,14例行补片移植血管成形术。——医院总死亡率为4.1%。纤维发育不良性疾病患者无死亡,动脉粥样硬化患者死亡率为6.8%。随访的185例患者的晚期死亡率为9.2%,中风和心肌梗死是最常见的死亡原因。术后,动脉粥样硬化患者中有36%血压正常,纤维发育不良性疾病患者中有70%血压正常。纤维发育不良性疾病患者中有53%血压改善。重建后2年、4年和6年,这些关系无明显变化。结果表明,在未选择的患者组中,纤维发育不良性狭窄患者肾动脉重建预后良好,动脉粥样硬化患者手术存在局限性。尽管经皮腔内扩张术的引入拓宽了肾血管性高血压的治疗可能性,但确切的适应症和强化的术后护理仍然是必要的。